A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective Anticoagulation Length with low molecular weight heparin In the treatment of Cancer Associated Thrombosis (ALICAT): study protocol for a mixed-methods study

BACKGROUND: Venous thromboembolism is common in patients with cancer and requires anticoagulation with low molecular weight heparin. Current data informs anticoagulation as far as six months, yet guidelines recommend anticoagulation beyond six months in patients who have locally advanced or metastat...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Smith, Joanna D, Baillie, Jessica, Baglin, Trevor, Griffiths, Gareth O, Casbard, Angela, Cohen, David, Fitzmaurice, David A, Hood, Kerenza, Rose, Peter, Cohen, Alexander T, Johnson, Miriam, Maraveyas, Anthony, Bell, John, Toone, Harold, Nelson, Annmarie, Noble, Simon I
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: BioMed Central 2014
Θέματα:
Study Protocol
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4003288/
https://ncbi.nlm.nih.gov/pubmed/24726032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-122
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια